Respiratory syncytial virus and other respiratory virus infections in residents of homeless shelters - King County, Washington, 2019-2021.


Journal

Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 27 03 2023
revised: 26 05 2023
accepted: 27 05 2023
medline: 26 6 2023
pubmed: 22 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Respiratory syncytial virus (RSV) causes disproportionate morbidity and mortality in vulnerable populations. We tested residents of homeless shelters in Seattle, Washington for RSV in a repeated cross-sectional study as part of community surveillance for respiratory viruses. Of 15 364 specimens tested, 35 had RSV detected, compared to 77 with influenza. The most common symptoms for both RSV and influenza were cough and rhinorrhea. Many individuals with RSV (39%) and influenza (58%) reported that their illness significantly impacted their ability to perform their regular activities. RSV and influenza demonstrated similar clinical presentations and burden of illness in vulnerable populations living in congregate settings.

Identifiants

pubmed: 37346095
doi: 10.1111/irv.13166
pii: IRV13166
pmc: PMC10279995
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13166

Informations de copyright

© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

Dr. E. Chow reported honoraria from Providence Health & Services, Renton, Washington for presentations on COVID‐19. Dr. P. Roychoudhury reported honoraria from The Bill & Melinda Gates Foundation and Association for Molecular Pathology for presentations on COVID‐19. Dr. M. Boeckh reported consulting with GlaxoSmithKline and Janssen and has received research support from Janssen, outside the submitted work. Dr. A. Greninger reports contract testing from Abbott and research support from Gilead and Merck. Dr. J. Englund reported consulting with Sanofi Pasteur, AstraZeneca, and Meissa Vaccines, and has received research funding from AstraZeneca, GlaxoSmithKline, Merck, and Pfizer outside the submitted work. Dr. H. Chu reported consulting with Ellume, Pfizer, The Bill and Melinda Gates Foundation, Glaxo Smith Kline, Abbvie, and Merck. She has received research funding from Gates Ventures, Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work. All other authors report no conflicts of interest. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Références

Am J Prev Med. 2010 Aug;39(2):164-72
pubmed: 20621264
N Engl J Med. 2020 Jul 9;383(2):185-187
pubmed: 32356944
Emerg Infect Dis. 2019 Jul;25(7):1408-1411
pubmed: 31211675
Clin Microbiol Infect. 2021 Oct;27(10):1520.e1-1520.e5
pubmed: 34111590
Clin Chem. 2020 Jul 1;66(7):966-972
pubmed: 32379863
JAMA Netw Open. 2021 Mar 1;4(3):e210490
pubmed: 33651111
J Clin Microbiol. 2016 Dec 28;55(1):177-182
pubmed: 27795347
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Clin Infect Dis. 2021 Jul 1;73(1):e158-e163
pubmed: 32531019
Influenza Other Respir Viruses. 2023 Jan;17(1):e13092
pubmed: 36610058
BMJ Open. 2020 Oct 7;10(10):e037295
pubmed: 33033018
Clin Infect Dis. 2021 Dec 6;73(11):e4411-e4418
pubmed: 33197930
South Med J. 2010 Jan;103(1):18-24
pubmed: 19996848
Chest. 2004 May;125(5):1719-25
pubmed: 15136382

Auteurs

Denise J McCulloch (DJ)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.
Vaccine and Infectious Disease Division Fred Hutchinson Cancer Center Seattle Washington USA.

Julia H Rogers (JH)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.
Department of Epidemiology University of Washington Seattle Washington USA.

Yongzhe Wang (Y)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.

Eric J Chow (EJ)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.

Amy C Link (AC)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.

Caitlin R Wolf (CR)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.

Timothy M Uyeki (TM)

Division of Influenza National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Atlanta Georgia USA.

Melissa A Rolfes (MA)

Division of Influenza National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Atlanta Georgia USA.

Emily Mosites (E)

Office of the Deputy Director for Infectious Diseases Centers for Disease Control and Prevention Atlanta Georgia USA.

Jaydee Sereewit (J)

Department of Laboratory Medicine and Pathology University of Washington Seattle Washington USA.

Jeffrey S Duchin (JS)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.
Public Health-Seattle & King County Seattle Washington USA.

Nancy K Sugg (NK)

Department of Medicine University of Washington Seattle Washington USA.

Alexander L Greninger (AL)

Department of Laboratory Medicine and Pathology, Division of Virology University of Washington Seattle Washington USA.

Michael J Boeckh (MJ)

Vaccine and Infectious Disease Division Fred Hutchinson Cancer Center Seattle Washington USA.

Janet A Englund (JA)

Seattle Children's Research Institute Seattle Washington USA.

Jay Shendure (J)

Department of Genome Sciences University of Washington Seattle Washington USA.
Brotman Baty Institute for Precision Medicine Seattle Washington USA.
Allen Discovery Center for Cell Lineage Tracing Seattle Washington USA.
Howard Hughes Medical Institute Seattle Washington USA.

James P Hughes (JP)

Department of Biostatistics University of Washington Seattle Washington USA.

Lea M Starita (LM)

Department of Genome Sciences University of Washington Seattle Washington USA.
Brotman Baty Institute for Precision Medicine Seattle Washington USA.

Pavitra Roychoudhury (P)

Vaccine and Infectious Disease Division Fred Hutchinson Cancer Center Seattle Washington USA.
Department of Laboratory Medicine and Pathology, Division of Virology University of Washington Seattle Washington USA.

Helen Y Chu (HY)

Department of Medicine, Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH